Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Charles River Laboratories has appointed former FDA Principal Deputy Commissioner Namandjé N. Bumpus, Ph.D., to chair its newly established Scientific Advisory Board, guiding the company’s strategy to advance New Approach Methodologies (NAMs) that ...
read more
Wednesday, October 15, 2025
MilliporeSigma announced that the Life Science business of Merck KGaA, Darmstadt, Germany has signed a definitive agreement to acquire the chromatography business of JSR Life Sciences, a provider of contract development and manufacturing, preclinical...
read more
Wednesday, October 15, 2025
LTS LOHMANN Therapie-Systeme AG announced the acquisition of Renaissance Lakewood, a US-based contract development and manufacturing organization (CDMO) specializing in nasal sprays and sterile dosage forms.
read more
Wednesday, October 15, 2025
Sterling Pharma Solutions announced Karl Rotthier as CEO, effective October, 21st. Rotthier succeeds Kevin Cook, who has served as CEO since 2013 and has now taken the decision to retire. Kevin will work closely with Karl to ensure a smooth ...
read more
Tuesday, October 14, 2025
Halo Pharma appointed Laurent Malgouyres as Site Director for its facility in Mirabel, Quebec, Canada. In his new role, Malgouyres will oversee production, quality, and overall site performance.
read more
Tuesday, October 14, 2025
Quotient Sciences and Biorasi have announced a strategic partnership aimed at streamlining early phase clinical trials from Investigational New Drug (IND) applications to patient proof-of-concept (POC) milestones.
read more
Tuesday, October 14, 2025
Almac Group has unveiled a $48 million investment aimed at advancing eClinical technologies, highlighted by the debut of its new interoperable platform, Almac Trial Coordinator™.
read more
Tuesday, October 14, 2025
SteriPack, a contract design and manufacturing organization (CDMO) serving pharmaceutical and medical device industries, has officially changed its trading name to Ensera. The rebranding marks an expansion of services and a strategic shift in ...
read more
Tuesday, October 14, 2025
Codis, a newly established contract development and manufacturing organization (CDMO), has entered the pharmaceutical outsourcing market with a focus on commercial-scale spray drying and amorphous solid dispersion technologies.
read more
Thursday, October 09, 2025
Catalent has signed a global, non-exclusive license agreement with Lisata Therapeutics, securing rights to use Lisata’s proprietary certepetide peptide and its analogs in antibody-drug conjugates (ADCs) developed on Catalent’s SMARTag® technology ...
read more
Wednesday, October 08, 2025
Symeres has appointed Gabriella Gentile as Chief Operating Officer (COO). This strategic addition to the executive team supports Symeres’ transatlantic growth ambitions, building upon its strong foundations in existing and novel modalities.
read more
Wednesday, October 08, 2025
Lonza announced the operational readiness of its new aseptic drug product filling line in Stein, Switzerland. The filling line was granted a GMP license following Swissmedic approval, strengthening Lonza’s existing capacity for liquid and lyophilized...
read more
Wednesday, October 08, 2025
Recipharm has designated its Cuxhaven, Germany facility as a Centre of Excellence for analytical services supporting advanced therapy medicinal products (ATMPs) and biologics. The site now operates 500 m² of CGMP-compliant laboratories designed to ...
read more
Wednesday, October 08, 2025
The IMA Group has announced its acquisition of Chicago Research Center (CRC), a move that expands the company’s clinical trial footprint and marks its entry into dedicated sleep research.
read more
Tuesday, October 07, 2025
OXB, a cell and gene therapy CDMO, has signed and closed an asset purchase transaction to acquire a custom-built, state-of-the-art cell and gene therapy viral vector manufacturing facility in North Carolina from RTP Operating, LLC, a subsidiary of ...
read more